BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 25510644)

  • 1. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voluntary wheel running differentially affects disease outcomes in male and female mice with experimental autoimmune encephalomyelitis.
    Mifflin KA; Frieser E; Benson C; Baker G; Kerr BJ
    J Neuroimmunol; 2017 Apr; 305():135-144. PubMed ID: 28284334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise.
    Bernardes D; Oliveira-Lima OC; Silva TV; Faraco CC; Leite HR; Juliano MA; Santos DM; Bethea JR; Brambilla R; Orian JM; Arantes RM; Carvalho-Tavares J
    J Neuroimmunol; 2013 Nov; 264(1-2):24-34. PubMed ID: 24054000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
    Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
    J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
    Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE).
    Benson C; Paylor JW; Tenorio G; Winship I; Baker G; Kerr BJ
    Exp Neurol; 2015 Sep; 271():279-90. PubMed ID: 26033473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
    Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
    Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
    Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW
    J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
    Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis.
    Rossi S; Furlan R; De Chiara V; Musella A; Lo Giudice T; Mataluni G; Cavasinni F; Cantarella C; Bernardi G; Muzio L; Martorana A; Martino G; Centonze D
    Neurobiol Dis; 2009 Oct; 36(1):51-9. PubMed ID: 19591937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.
    Bannerman PG; Hahn A; Ramirez S; Morley M; Bönnemann C; Yu S; Zhang GX; Rostami A; Pleasure D
    Brain; 2005 Aug; 128(Pt 8):1877-86. PubMed ID: 15901645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
    Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
    J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
    Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
    Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
    Prochnow N; Gold R; Haghikia A
    J Neuroimmunol; 2013 Nov; 264(1-2):48-53. PubMed ID: 24090654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
    Frezel N; Sohet F; Daneman R; Basbaum AI; Braz JM
    Exp Neurol; 2016 Sep; 283(Pt A):224-34. PubMed ID: 27343802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.